160 related articles for article (PubMed ID: 10436426)
1. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume.
Kirkali Z; Güzelsoy M; Mungan MU; Kirkali G; Yörükoglu K
Urol Int; 1999; 62(1):21-5. PubMed ID: 10436426
[TBL] [Abstract][Full Text] [Related]
2. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume.
Partin AW; Criley SR; Steiner MS; Hsieh K; Simons JW; Lumadue J; Carter HB; Marshall FF
Urology; 1995 Feb; 45(2):211-7. PubMed ID: 7855968
[TBL] [Abstract][Full Text] [Related]
3. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage.
Singh KJ; Singh SK; Suri A; Vijjan V; Goswami AK; Khullar M
Indian J Cancer; 2005; 42(4):197-200. PubMed ID: 16391438
[TBL] [Abstract][Full Text] [Related]
4. Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma.
Miyata Y; Koga S; Nishikido M; Hayashi T; Kanetake H
BJU Int; 2001 Dec; 88(9):974-7. PubMed ID: 11851623
[TBL] [Abstract][Full Text] [Related]
5. Ferritin: a tumor marker expressed by renal cell carcinoma.
Kirkali Z; Esen AA; Kirkali G; Güner G
Eur Urol; 1995; 28(2):131-4. PubMed ID: 8529738
[TBL] [Abstract][Full Text] [Related]
6. [Serum ferritin determination: is it useful in the early diagnosis of renal carcinoma?].
D'Addessi A; Racioppi M; Zappacosta B; Fanasca A; De Michele T; Alcini E
Arch Ital Urol Androl; 1997 Dec; 69(5):283-6. PubMed ID: 9477611
[TBL] [Abstract][Full Text] [Related]
7. Serum ferritin: a tumor marker for renal cell carcinoma.
Essen A; Ozen H; Ayhan A; Ergen A; Tasar C; Remzi F
J Urol; 1991 Jun; 145(6):1134-7. PubMed ID: 2033679
[TBL] [Abstract][Full Text] [Related]
8. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.
Miyata Y; Koga S; Nishikido M; Noguchi M; Kanda S; Hayashi T; Saito Y; Kanetake H
Urology; 2001 Aug; 58(2):161-4. PubMed ID: 11489689
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin in renal cell carcinoma: evaluation of its usefulness as a tumor marker.
Ljungberg B; Rasmuson T; Grankvist K
Eur Urol; 1992; 21(2):160-3. PubMed ID: 1499617
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum ferritin in patients with renal cell carcinoma.
Ozen H; Uygur C; Sahin A; Tekgül S; Ergen A; Remzi D
Urology; 1995 Oct; 46(4):494-8. PubMed ID: 7571217
[TBL] [Abstract][Full Text] [Related]
11. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
[TBL] [Abstract][Full Text] [Related]
12. Pretherapeutic Plasma Fibrinogen Level is an Independent Survival Predictor in Renal Cell Carcinoma.
Sasaki T; Onishi T
Oncol Res Treat; 2015; 38(7-8):374-8. PubMed ID: 26278582
[TBL] [Abstract][Full Text] [Related]
13. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
14. The effect of tumor volume on survival in patients with renal cell carcinoma.
Seçil M; Çullu N; Aslan G; Mungan U; Uysal F; Tuna B; Yörükoğlu K
Diagn Interv Radiol; 2012; 18(5):480-7. PubMed ID: 22618630
[TBL] [Abstract][Full Text] [Related]
15. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
Wechsel HW; Petri E; Bichler KH; Feil G
Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.
Ramankulov A; Lein M; Kristiansen G; Meyer HA; Loening SA; Jung K
J Cancer Res Clin Oncol; 2007 Sep; 133(9):643-52. PubMed ID: 17479289
[TBL] [Abstract][Full Text] [Related]
17. Tissue polypeptide-specific antigen in renal cell carcinoma.
Höbarth K; Hallas A; Kramer G; Aulitzky W; Gomahr A; Steiner G; Marberger M
Eur Urol; 1996; 30(1):89-95. PubMed ID: 8854074
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma.
Gayed BA; Gillen J; Christie A; Peña-Llopis S; Xie XJ; Yan J; Karam JA; Raj G; Sagalowsky AI; Lotan Y; Margulis V; Brugarolas J
BMC Urol; 2015 Apr; 15():24. PubMed ID: 25885592
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of serum levels of CEA, CA 50, and ferritin in the management of renal cell cancer.
Kokociñska D; Rajchel K; Nalewajka E; Zagalski K
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):279-81. PubMed ID: 9216822
[TBL] [Abstract][Full Text] [Related]
20. Serum M65 as a biomarker for metastatic renal cell carcinoma.
Yildiz I; Sen F; Kilic L; Keskin S; Duranyildiz D; Bilgin E; Disci R; Ekenel M; Darendeliler E; Bavbek S; Basaran M
Clin Genitourin Cancer; 2013 Sep; 11(3):290-6. PubMed ID: 23391372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
